HeyJaredKristin Emery
- Indexed articles, last 90 days
- 4
- Latest publication
- Aug 29, 2026
- Outlet visibility, for Observer-Reporter
- Top 1M sites
- Earliest in this view
- Jul 16, 2026
Latest articles
‘Hope and dignity’ (opens the original)
Read excerpt
It’s hard to describe inspiration, but you know it when you see it or feel it. For Grace Reid-Vensel, the inspiration for a way to help her community came from enduring the COVID-19 pandemic. “I was a 16-year-old junior in high school in the wake of the pandemic,” Grace remembers. “My family and the families of so many of my peers were facing financial struggle. I saw my friends changing into their work uniforms 15 minutes before school let out and returning to school the next day, barely able t
New research eases fear of GLP-1 during early pregnancy (opens the original)
Read excerpt
GLP-1 drug use among women of reproductive age is increasing across the United States, and while experts recommend stopping the drugs before getting pregnant, sometimes unintentional early exposure happens. Now, a new study is offering some reassurance for women in that situation. The study published in Annals of Internal Medicine looked at 3,600 women ages 16 to 55 and found similar risk of pregnancy loss, abnormal fetal growth and major congenital malformations when comparing pregnancies where
Mon Valley Performing Arts Academy keeping arts education alive (opens the original)
Read excerpt
When Michele Pagen was growing up in the Mon Valley, she could only dream of having a special place to go to study music, theater and all sorts of performing arts. “I grew up in this area and always knew that if I was given the opportunity, I would start a program such as this,” says Pagen, now the Artistic Director of the Mon Valley Performing Arts Academy (MVPAA). “The only one around me when I was young was in Pittsburgh and, for my parents, that might as well have been Europe. I also wanted
Study: New pancreatic cancer drug doubled survival time (opens the original)
Read excerpt
The fight against deadly pancreatic cancer took a positive turn this spring with a study finding a new drug can help patients live longer. The New England Journal of Medicine (JAMA) published the study showing daraxonrasib taken daily as a pill helped metastatic pancreatic cancer patients live for a median of 13.2 months compared with 6.7 months for those being treated with chemotherapy. The findings are groundbreaking, as pancreatic cancer is one of the deadliest types of cancer with the five-y
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For Observer-Reporter, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.